Zentek (CVE:ZEN) Trading Up 6% – Time to Buy?

Zentek Ltd. (CVE:ZENGet Free Report)’s share price shot up 6% on Tuesday . The stock traded as high as C$0.79 and last traded at C$0.71. 528,136 shares were traded during trading, an increase of 239% from the average daily volume of 155,682 shares. The stock had previously closed at C$0.67.

Zentek Stock Performance

The company has a market cap of C$92.43 million, a P/E ratio of -8.11 and a beta of 0.69. The firm has a 50 day moving average of C$0.76 and a 200-day moving average of C$0.85. The company has a quick ratio of 7.59, a current ratio of 0.64 and a debt-to-equity ratio of 19.52.

Zentek Company Profile

(Get Free Report)

Zentek Ltd., together with its subsidiaries, engages in the research and development of graphene and related nanomaterials in Canada. The company develops graphene-based antimicrobial coating under the ZenGUARD brand, surgical masks, HVAC filters, personal protective equipment, rapid detection point of care diagnostics tests, and pharmaceutical products based on graphene-based compounds. It is also developing graphene oxide synthesis and graphene synthesis. In addition, the company owns 100% interest in the Albany graphite project located in Northern Ontario, Canada.

Featured Stories

Receive News & Ratings for Zentek Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Zentek and related companies with MarketBeat.com's FREE daily email newsletter.